Mylan

Yupelri

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / Yupelri – J7677

Manufacturer:

Mylan

Name:

Yupelri

HCPCS Code Descriptor:

Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram

Category:

J Code

HCPCS:

J7677

NDC(s):

49502-0806-93

Primary Type:

Respiratory

Generic/Specialty Status:

Single-Source

Route of Administration:

Inhalation

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About:

Yupelri is a Respiratory drug manufactured by Mylan and administered via the Inhalation route of administration. The J Code: J7677 is aligned to the drug Yupelri.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

7/1/19

HCPCS Effective Date:

7/1/19

HCPCS Short Description:

Revefenacin inh non-com 1mcg

Billing and Coding Guide:

https://www.yupelrihcp.com/-/media/Project/Common/YupelriHCP/pdf/REV_2020_0151_Billing_Reimbursement-Guide.pdf

Patient Assistance:

https://www.viatris.com/en-us/lm/united-states/patient-assistance-program

Yupelri - J7677